Unleashing Potential | Dana-Farber Cancer Institute
AI-based cancer diagnostic tools have fit rather seamlessly into clinical practice. They have also hinted at the potential for AI to benefit patients in other ways.
AI-based cancer diagnostic tools have fit rather seamlessly into clinical practice. They have also hinted at the potential for AI to benefit patients in other ways.
This cross-sectional study assesses homologous recombination repair mutation genetic testing and associated characteristics among men with metastatic castration-resistant prostate cancer (mCRPC).
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
The investigational therapy IGNK001 has received orphan drug designation from the FDA for patients with acute myeloid leukemia.
Mark D. Tyson, II, MD, MPH, discusses findings from the phase 3 BOND-003 trial in BCG-unresponsive non–muscle-invasive bladder cancer with CIS.
Chidamide plus R-CHOP has received approval from China’s NMPA for the management of diffuse large B-cell lymphoma.
Myelofibrosis (MF) is a hematologic malignancy that causes progressive bone marrow fibrosis and presents with other clinical manifestations, including anemia…
Stacey Stein, MD, discusses the background and outcomes of the IMbrave150 trial of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma.
Volume 167, issue 2 articles listing for Journal of Neuro-Oncology
JCO Oncology Advances (JCO OA) is a fully open-access, online-only, and interdisciplinary journal committed to accelerating progress in the global fight against cancer. By providing…
Researchers investigated whether listening to mindfulness audio recordings may alleviate the side effects of radiation therapy in men with prostate cancer.